Author

Chinmay Kr. Panda

Chittaranjan National Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Arindam MaitraiD· 1 shared Bidyut RoyiD· 1 shared Debodipta DasiD· 1 shared Partha Pratim MajumderiD· 1 shared Rajiv SariniD· 1 shared Sandip GhoseiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Arindam MaitraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

EMT, angiogenesis, and cell-cycle pathways are significantly impacted in oral cancer patients, among whom a large fraction may potentially respond to immune checkpoint therapy

Debodipta Das, Arindam Maitra, Chinmay Kr. Panda, Sandip Ghose, Bidyut Roy, Rajiv Sarin, Partha Pratim Majumder

The paper identifies molecular pathways and immune markers in oral cancer, suggesting potential for immune checkpoint therapy in specific patient subtypes.

Molecular Medicine · Apr 11, 2026Peer-reviewedGenetic & Genomic Medicine